Primary Umbilical Endometriosis: Villar’s Nodule

Christos Iavazzo; Nikolaos Vrachnis; Ioannis D Gkegkes

doi:10.4274/mmj.galenos.2022.48865

Primary Umbilical Endometriosis: Villar’s Nodule

Christos Iavazzo, Nikolaos Vrachnis, Ioannis D Gkegkes

Medeniyet medical journal · 2022 · vol. 37(1) , pp. 123–124 · doi:10.4274/mmj.galenos.2022.48865 · PMID:35306800 · PMC8939447 · W4210596591

article OA: gold CC0 ⤵ 1 in-corpus citation

📄 Open PDF Full text JSON View on OpenAlex View on PubMed View at publisher

⚙ AI-generated summary by claude@2026-06, 2026-06-10 ⓘ

This paper reviews the pathogenesis of primary umbilical endometriosis, a condition often stimulated by inflammation, and discusses potential pathways involving endometrial tissue migration.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-10 · read from full text ⓘ

This short 2022 article reports on primary umbilical endometriosis, presented as Villar’s nodule, but the available text does not include details on the patient population, methods, diagnostic approach, or outcomes. No specific findings are provided in the text excerpt beyond the title-level focus on this condition. A major limitation is that the full PDF content is not available here, so the study design and evidentiary basis cannot be verified. This paper is centrally about endometriosis — it focuses specifically on primary umbilical endometriosis (Villar’s nodule).

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The pathogenesis of primary cutaneous endometriosis is still unknown with the umbilicus being the most common site. The pathogenetic pathways may include migration of endometrial tissue either lymphatic or vascular as well as cellular metaplasia and in the majority of the cases is stimulated by inflammation 2 .

Full text 565 characters · extracted from oa-html · click to expand

Article is only available in PDF format. Show PDF Medeni Med J 2022;37(1):123-124 1. Gynaecological Oncology Department, Metaxa Cancer Hospital, Piraeus, Greece 2. Third Department Of Obstetrics And Gynaecology, National And Kapodistrian University Of Athens Medical School, Attikon Hospital, Athens, Greece 3. Department Of Colorectal Surgery, Royal Devon And Exeter Nhs Foundation Trust, Exeter, United Kingdom No information available. No information available Received Date: 17.01.2022 Accepted Date: 18.03.2022 Article is only available in PDF format. Show PDF

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works